article_metadata: Youjia Li Kai Qu Xiuli Li Xin Yang Kanghuai Zhang Jiao Xie
article_metadata: 10.3389/fimmu.2025.1505195
article_metadata: Front Immunol
article_metadata: 2025 Jan 28:16:1505195.
article_metadata: pd-l1 diabetic ketoacidosis envafolimab hepatocellular carcinoma immune checkpoint inhibitor type 1 diabetes mellitus
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39958361/
article_metadata: Carcinoma, Hepatocellular / drug therapy Carcinoma, Hepatocellular / therapy Diabetes Mellitus, Type 1 / complications Diabetes Mellitus, Type 1 / drug therapy Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / etiology Diabetic Ketoacidosis / therapy Liver Neoplasms / drug therapy
article_metadata: Carcinoma, Hepatocellular / drug therapy Carcinoma, Hepatocellular / therapy Diabetes Mellitus, Type 1 / complications Diabetes Mellitus, Type 1 / drug therapy Diabetic Ketoacidosis / chemically induced Diabetic Ketoacidosis / etiology Diabetic Ketoacidosis / therapy Liver Neoplasms / drug therapy Case Reports Humans Immune Checkpoint Inhibitors / adverse effects Immune Checkpoint Inhibitors / therapeutic use Male Middle Aged Immune Checkpoint Inhibitors
article_metadata: PMC11827420
article_metadata: 39958361
article_metadata: Case report: A case of type 1 diabetes with diabetic ketoacidosis induced by envafolimab treatment in hepatocellular carcinoma
article_metadata: 2025